G217-0260 Screening compound: N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

G217-0260 Screening compound: N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide
G217-0260 Screening compound: N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G217-0260
N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G217-0260

Molecular Formula

C29H33N3O3 (C29 H33 N3 O3)

Compound Name

N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide

IUPAC name

N-(4-{[(4-butoxyphenyl)methyl]carbamoyl}phenyl)-2345-tetrahydro-1H-1-benzazepine-1-carboxamide

SMILES

CCCCOc1ccc(CNC(c(cc2)ccc2NC(N(CCCC2)c3c2cccc3)=O)=O)cc1

InChI

InChI=1S/C29H33N3O3/c1-2-3-20-35-26-17-11-22(12-18-26)21-30-28(33)24-13-15-25(16-14-24)31-29(34)32-19-7-6-9-23-8-4-5-10-27(23)32/h4-5,8,10-18H,2-3,6-7,9,19-21H2,1H3,(H,30,33)(H,31,34)

InChI Key

UBJUFEBRRXBUEH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14987388

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.295

Distribution Coefficient, logD

6.295

Water Solubility, LogSw

-5.42

Polar Surface Area

56.534

Acid Dissociation Constant (pKa)

11.11

Base Dissociation Constant (pKb)

-0.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

G217-0260 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G217-0260 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G217-0260?
Check Price and Availability of G217-0260, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G217-0260 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G217-0260
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G217-0260
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G217-0260 available by request